{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:38Z","timestamp":1790610758314,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81330016, 81630038, 81771634, 81842011"],"award-info":[{"award-number":["81330016, 81630038, 81771634, 81842011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key R&D Program of China","award":["2017YFA 0104200"],"award-info":[{"award-number":["2017YFA 0104200"]}]},{"name":"the grants from the Ministry of Education of China","award":["IRT0935"],"award-info":[{"award-number":["IRT0935"]}]},{"DOI":"10.13039\/501100006723","name":"Institute for NanoScience and NanoTechnology, Sharif University of Technology","doi-asserted-by":"crossref","award":["2016TD0002"],"award-info":[{"award-number":["2016TD0002"]}],"id":[{"id":"10.13039\/501100006723","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the grant from the clinical discipline program (Neonatology) from the Ministry of Health of China","award":["1311200003303"],"award-info":[{"award-number":["1311200003303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Pulmonary tuberculosis (PTB) is a major health and economic burden. Accurate PTB detection is an important step to eliminating TB globally. Interferon gamma-induced protein 10 (IP-10) has been reported as a potential diagnostic marker for PTB since 2007. In this study, a meta-analysis approach was used to assess diagnostic value of IP-10 for PTB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Web of Science, PubMed, the Cochrane Library, and Embase databases were searched for studies published in English up to February 2019. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), the area under the curve (AUC) and hierarchical summary receiver operating characteristic (HSROC) curve were estimated by the HSROC model and random effect model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighteen studies including 2836 total participants met our inclusion criteria. The pooled sensitivity, specificity, PLR, and NLR of IP-10 for PTB detection were 86, 88%, 7.00, and 0.16, respectively. The pooled DOR was 43.01, indicating a very powerful discriminatory ability of IP-10. The AUC was 0.93 (95% CI: 0.91\u20130.95), showed the accuracy of IP-10 was good. Meta-regression showed that there was no heterogeneity with respect to TB burden, study design type, age, IP-10 assay method, IP-10 condition and HIV-infection status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results showed that IP-10 is a promising marker for differentiating PTB from non-TB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-019-4466-5","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T19:03:14Z","timestamp":1572462194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Xia","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"issue":"9785","key":"4466_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","volume":"378","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57\u201372.","journal-title":"Lancet"},{"key":"4466_CR2","unstructured":"The World Health Organizations. Global tuberculosis report 2018. Available at: \n                    www.aidsdatahub.org\/global-tuberculosis-report-2018-who-2018\n                    \n                  ."},{"issue":"2","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1183\/09031936.00007814","volume":"44","author":"CM Denkinger","year":"2014","unstructured":"Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB\/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435\u201346.","journal-title":"Eur Respir J"},{"issue":"1","key":"4466_CR4","doi-asserted-by":"publisher","first-page":"20714","DOI":"10.7448\/IAS.19.1.20714","volume":"19","author":"N Ford","year":"2016","unstructured":"Ford N, Matteelli A, Shubber Z, Hermans S, Meintjes G, Grinsztejn B, et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19(1):20714.","journal-title":"J Int AIDS Soc"},{"key":"4466_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O'Garra","year":"2013","unstructured":"O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475\u2013527.","journal-title":"Annu Rev Immunol"},{"issue":"9729","key":"4466_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","volume":"375","author":"RS Wallis","year":"2010","unstructured":"Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010;375(9729):1920\u201337.","journal-title":"Lancet"},{"key":"4466_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tube.2018.05.004","volume":"111","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Yang X, Zhang X, Yu Q, Zhao P, Wang J, et al. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring. Tuberculosis. 2018;111:45\u201353.","journal-title":"Tuberculosis"},{"issue":"3","key":"4466_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/thx.2010.143396","volume":"66","author":"TG Connell","year":"2011","unstructured":"Connell TG, Tebruegge M, Ritz N, Bryant P, Curtis N. The potential danger of a solely interferon-gamma release assay-based approach to testing for latent mycobacterium tuberculosis infection in children. Thorax. 2011;66(3):263\u20134.","journal-title":"Thorax"},{"issue":"8","key":"4466_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","volume":"28","author":"T Haustein","year":"2009","unstructured":"Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28(8):669\u201373.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"4466_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micinf.2004.09.004","volume":"7","author":"A Azzurri","year":"2005","unstructured":"Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G, et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in mycobacterium tuberculosis infection. Microbes Infect. 2005;7(1):1\u20138.","journal-title":"Microbes Infect"},{"issue":"6","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmi.2018.12.006","volume":"25","author":"X Qiu","year":"2019","unstructured":"Qiu X, Tang Y, Yue Y, Zeng Y, Li W, Qu Y, et al. Accuracy of interferon-\u03b3-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(6):667\u201372.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"4466_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1183\/09031936.00129412","volume":"42","author":"MG Aabye","year":"2013","unstructured":"Aabye MG, Latorre I, Diaz J, Maldonado J, Mialdea I, Eugen-Olsen J, et al. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J. 2013;42(2):495\u2013503.","journal-title":"Eur Respir J"},{"key":"4466_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tube.2015.04.013","volume":"98","author":"T Blauenfeldt","year":"2016","unstructured":"Blauenfeldt T, Wagner D, Aabye M, Heyckendorf J, Lange B, Lange C, et al. Thermostability of IFN-gamma and IP-10 release assays for latent infection with mycobacterium tuberculosis: a TBnet study. Tuberculosis. 2016;98:7\u201312.","journal-title":"Tuberculosis"},{"issue":"36","key":"4466_CR14","doi-asserted-by":"publisher","first-page":"57581","DOI":"10.18632\/oncotarget.11420","volume":"7","author":"R Jacobs","year":"2016","unstructured":"Jacobs R, Malherbe S, Loxton AG, Stanley K, van der Spuy G, Walzl G, et al. Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response. Oncotarget. 2016;7(36):57581\u201392.","journal-title":"Oncotarget"},{"issue":"2","key":"4466_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5588\/ijtld.14.0525","volume":"19","author":"K Lee","year":"2015","unstructured":"Lee K, Chung W, Jung Y, Kim Y, Park J, Sheen S, et al. CXCR3 ligands as clinical markers for pulmonary tuberculosis. Int J Tuberc Lung Dis. 2015;19(2):191\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4466_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ejcdt.2013.08.009","volume":"62","author":"NY Azab","year":"2013","unstructured":"Azab NY, Elmahallawy I, Sharara G, Abdel-Atti E. The utility of the interferon gamma-inducible protein-10 (IP-10) level in bronchoalveolar lavage and blood in the diagnosis of tuberculosis. Egypt J Chest Dis Tuberc. 2013;62:629\u201334.","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"6","key":"4466_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tube.2012.06.005","volume":"92","author":"X Wang","year":"2012","unstructured":"Wang X, Jiang J, Cao Z, Yang B, Zhang J, Cheng X. Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis. Tuberculosis. 2012;92(6):513\u201320.","journal-title":"Tuberculosis"},{"issue":"12","key":"4466_CR18","doi-asserted-by":"publisher","first-page":"E855","DOI":"10.1016\/j.ijid.2012.07.013","volume":"16","author":"JY Hong","year":"2012","unstructured":"Hong JY, Jung GS, Kim H, Kim YM, Lee HJ, Cho S-N, et al. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. Int J Infect Dis. 2012;16(12):E855\u2013E9.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"e9051","DOI":"10.1371\/journal.pone.0009051","volume":"5","author":"B Syed Ahamed Kabeer","year":"2010","unstructured":"Syed Ahamed Kabeer B, Raman B, Thomas A, Perumal V, Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One. 2010;5(2):e9051.","journal-title":"PLoS One"},{"issue":"4","key":"4466_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jinf.2018.10.017","volume":"78","author":"J Luo","year":"2018","unstructured":"Luo J, Zhang M, Yan B, Li F, Guan S, Chang K, et al. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages of mycobacterium tuberculosis infection. J Infect. 2018;78(4):281\u201391.","journal-title":"J Infect"},{"issue":"3","key":"4466_CR21","doi-asserted-by":"publisher","first-page":"e0192664","DOI":"10.1371\/journal.pone.0192664","volume":"13","author":"MP La Manna","year":"2018","unstructured":"La Manna MP, Orlando V, Li Donni P, Sireci G, Di Carlo P, Cascio A, et al. Identification of plasma biomarkers for discrimination between tuberculosis infection\/disease and pulmonary non tuberculosis disease. PLoS One. 2018;13(3):e0192664.","journal-title":"PLoS One"},{"key":"4466_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tube.2018.08.006","volume":"112","author":"ME Balcells","year":"2018","unstructured":"Balcells ME, Ruiz-Tagle C, Tiznado C, Garcia P, Naves R. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection. Tuberculosis. 2018;112:110\u20139.","journal-title":"Tuberculosis"},{"key":"4466_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.tube.2017.04.005","volume":"105","author":"D Nonghanphithak","year":"2017","unstructured":"Nonghanphithak D, Reechaipichitkul W, Namwat W, Naranbhai V, Faksri K. Chemokines additional to IFN-gamma can be used to differentiate among mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype. Tuberculosis. 2017;105:28\u201334.","journal-title":"Tuberculosis"},{"issue":"1","key":"4466_CR24","doi-asserted-by":"publisher","first-page":"e0146098","DOI":"10.1371\/journal.pone.0146098","volume":"11","author":"IA Biraro","year":"2016","unstructured":"Biraro IA, Kimuda S, Egesa M, Cose S, Webb EL, Joloba M, et al. The use of interferon gamma inducible protein 10 as a potential biomarker in the diagnosis of latent tuberculosis infection in Uganda. PLoS One. 2016;11(1):e0146098.","journal-title":"PLoS One"},{"issue":"4","key":"4466_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jinf.2014.12.019","volume":"70","author":"I Wergeland","year":"2015","unstructured":"Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, et al. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. J Infect. 2015;70(4):381\u201391.","journal-title":"J Infect"},{"key":"4466_CR26","doi-asserted-by":"publisher","first-page":"589471","DOI":"10.1155\/2015\/589471","volume":"2015","author":"L Petrone","year":"2015","unstructured":"Petrone L, Cannas A, Aloi F, Nsubuga M, Sserumkuma J, Nazziwa RA, et al. Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children. Biomed Res Int. 2015;2015:589471.","journal-title":"Biomed Res Int"},{"issue":"6","key":"4466_CR27","first-page":"590","volume":"69","author":"I Latorre","year":"2014","unstructured":"Latorre I, Diaz J, Mialdea I, Serra-Vidal M, Altet N, Prat C, et al. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children. J Inf Secur. 2014;69(6):590\u20139.","journal-title":"J Inf Secur"},{"issue":"12","key":"4466_CR28","doi-asserted-by":"publisher","first-page":"e51338","DOI":"10.1371\/journal.pone.0051338","volume":"7","author":"S Wang","year":"2012","unstructured":"Wang S, Diao N, Lu C, Wu J, Gao Y, Chen J, et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS One. 2012;7(12):e51338.","journal-title":"PLoS One"},{"issue":"2","key":"4466_CR29","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/JCM.02758-14","volume":"53","author":"YH Jeong","year":"2015","unstructured":"Jeong YH, Hur Y-G, Lee H, Kim S, Cho J-E, Chang J, et al. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production. J Clin Microbiol. 2015;53(2):504\u201310.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4466_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388\u201396.","journal-title":"JAMA"},{"issue":"8","key":"4466_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"key":"4466_CR32","volume-title":"Cochrane handbook for systematic reviews of diagnostic test accuracy","author":"P Macaskill","year":"2010","unstructured":"Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C, editors. Cochrane handbook for systematic reviews of diagnostic test accuracy; 2010."},{"issue":"19","key":"4466_CR33","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.942","volume":"20","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865\u201384.","journal-title":"Stat Med"},{"key":"4466_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1536867X0900900203","volume":"9","author":"RM Harbord","year":"2009","unstructured":"Harbord RM, Whiting P. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J. 2009;9:211\u201329.","journal-title":"Stata J"},{"issue":"11","key":"4466_CR35","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"9","key":"4466_CR36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882\u201393.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"4466_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1473-3099(16)30474-1","volume":"17","author":"HE Jenkins","year":"2017","unstructured":"Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285\u201395.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4466_CR38","doi-asserted-by":"publisher","first-page":"e1568","DOI":"10.1542\/peds.2014-1570","volume":"134","author":"LL Holm","year":"2014","unstructured":"Holm LL, Rose MV, Kimaro G, Bygbjerg IC, Mfinanga SG, Ravn P, et al. A comparison of interferon-gamma and IP-10 for the diagnosis of tuberculosis. Pediatrics. 2014;134(6):e1568\u201375.","journal-title":"Pediatrics"},{"issue":"9979","key":"4466_CR39","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799\u2013801.","journal-title":"Lancet"},{"issue":"1","key":"4466_CR40","first-page":"93","volume":"7","author":"SJ Guo","year":"2014","unstructured":"Guo SJ, Jia LQ, Hu QJ, Long HY, Pang CS, Wen FQ. Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis. Int J Clin Exp Med. 2014;7(1):93\u2013100.","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"4466_CR41","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1183\/09031936.00055508","volume":"32","author":"M Ruhwald","year":"2008","unstructured":"Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J. 2008;32(6):1607\u201315.","journal-title":"Eur Respir J"},{"issue":"2","key":"4466_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1586\/erm.11.97","volume":"12","author":"M Ruhwald","year":"2012","unstructured":"Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn. 2012;12(2):175\u201387.","journal-title":"Expert Rev Mol Diagn"},{"issue":"7","key":"4466_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1164\/rccm.201406-1165OC","volume":"191","author":"AM Mandalakas","year":"2015","unstructured":"Mandalakas AM, Kirchner HL, Walzl G, Gie RP, Schaaf HS, Cotton MF, et al. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care Med. 2015;191(7):820\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4466_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jinf.2012.03.017","volume":"65","author":"V Vanini","year":"2012","unstructured":"Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, Rianda A, et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect. 2012;65(1):49\u201359.","journal-title":"J Infect"},{"key":"4466_CR45","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1183\/09031936.00039010","volume":"36","author":"MG Aabye","year":"2010","unstructured":"Aabye MG, Ruhwald M, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Faurholt-Jepsen D, et al. Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J. 2010;36:1488\u201390.","journal-title":"Eur Respir J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4466-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T20:09:56Z","timestamp":1603915796000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4466-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4466-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.11284\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11284\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11284\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"29 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"924"}}